<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Neutralizing monoclonal antibodies against SARS-CoV-2</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>NMAbs’s name</th>
    <th>Type</th>
    <th>Source</th>
    <th>Preparation</th>
    <th>Target</th>
    <th>Assay and result</th>
    <th>Ref.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="2">3F11</td>
    <td rowspan="2">sdAb</td>
    <td rowspan="2">Human</td>
    <td rowspan="2">Humanized phage display library</td>
    <td rowspan="2">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 3.8 ng/ml;
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR29">29</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 436 ng/ml.
    </td>
   </tr>
   <tr>
    <td rowspan="3">BD-368-2</td>
    <td rowspan="3">IgG</td>
    <td rowspan="3">Human</td>
    <td rowspan="3">B cells of convalescent patients; Single cell sequencing</td>
    <td rowspan="3">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 1.2 ng/ml;
    </td>
    <td rowspan="3">
     <sup>
      <xref ref-type="bibr" rid="CR31">31</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 15 ng/ml;
    </td>
   </tr>
   <tr>
    <td>Full protection of mice: 20 mg/kg.</td>
   </tr>
   <tr>
    <td rowspan="3">ab1</td>
    <td rowspan="3">IgG</td>
    <td rowspan="3">Human</td>
    <td rowspan="3">Phage displayed Fab, scFv and VH libraries</td>
    <td rowspan="3">RBD</td>
    <td>Reporter Gene neutralization assay: 200 ng/ml;</td>
    <td rowspan="3">
     <sup>
      <xref ref-type="bibr" rid="CR32">32</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: ND
     <sub>100</sub> &lt; 400 ng/ml;
    </td>
   </tr>
   <tr>
    <td>Full protection of mice: 0.3 mg of IgG1 ab1.</td>
   </tr>
   <tr>
    <td rowspan="3">CB6</td>
    <td rowspan="3">IgG</td>
    <td rowspan="3">Human</td>
    <td rowspan="3">B cells of convalescent patients</td>
    <td rowspan="3">RBD</td>
    <td>PsV neutralization: ND
     <sub>50</sub> = 0.036 μg/ml;
    </td>
    <td rowspan="3">
     <sup>
      <xref ref-type="bibr" rid="CR33">33</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: ND
     <sub>50</sub> = 0.036 μg/ml;
    </td>
   </tr>
   <tr>
    <td>Protection of rhesus macaques: 50 mg/kg.</td>
   </tr>
   <tr>
    <td rowspan="2">B38</td>
    <td rowspan="2">IgG</td>
    <td rowspan="2">Human</td>
    <td rowspan="2">Peripheral blood of SARS-CoV-2- infected patients</td>
    <td rowspan="2">RBD</td>
    <td>LV neutralization: IC
     <sub>50</sub> = 0.177 µg/ml;
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR34">34</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Protection of mice: Lung viral load reduced by 32.8% compared with PBS control.</td>
   </tr>
   <tr>
    <td rowspan="2">H4</td>
    <td rowspan="2">IgG</td>
    <td rowspan="2">Human</td>
    <td rowspan="2">Peripheral blood of SARS-CoV-2- infected patients</td>
    <td rowspan="2">RBD</td>
    <td>LV neutralization: IC
     <sub>50</sub> = 0.896 µg/ml;
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR34">34</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Protection of mice: Lung viral load reduced by 26% compared with PBS control.</td>
   </tr>
   <tr>
    <td rowspan="2">
     <p>7B11</p>
     <p>18F3</p>
    </td>
    <td rowspan="2">IgG</td>
    <td rowspan="2">Mouse</td>
    <td rowspan="2">Animal immunization; hybridoma technology</td>
    <td rowspan="2">RBD</td>
    <td>PsV neutralization: IC
     <sub>80</sub> = 10 μg/ml.
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR35">35</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>PsV neutralization: IC
     <sub>80</sub> = 10 μg/ml.
    </td>
   </tr>
   <tr>
    <td>P2C-1F11</td>
    <td>IgG</td>
    <td>Human</td>
    <td>Plasma of convalescing patients</td>
    <td>RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 0.03 µg/ml.
    </td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR36">36</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>rRBD-15</td>
    <td>IgG</td>
    <td>Human</td>
    <td>A synthetic human Fab antibody library</td>
    <td>RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 12.2 nM.
    </td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR37">37</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>VHH-72-Fc</td>
    <td>HCAb</td>
    <td>llama</td>
    <td>Animal immunization and sequencing</td>
    <td>RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> ~ 0.2 µg/ml.
    </td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR25">25</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td rowspan="2">
     <p>311mab–31B5</p>
     <p>311mab–32D4</p>
    </td>
    <td rowspan="2">IgG</td>
    <td rowspan="2">Human</td>
    <td rowspan="2">B cells of convalescent patients</td>
    <td rowspan="2">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 33.8 ng/ml.
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR38">38</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>PsV neutralization: IC
     <sub>50</sub> = 69.8 ng/ml.
    </td>
   </tr>
   <tr>
    <td rowspan="3">CC12.1</td>
    <td rowspan="3">IgG</td>
    <td rowspan="3">Human</td>
    <td rowspan="3">B cells of convalescent patients</td>
    <td rowspan="3">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 0.019 μg/ml;
    </td>
    <td rowspan="3">
     <sup>
      <xref ref-type="bibr" rid="CR39">39</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 0.022 μg/ml;
    </td>
   </tr>
   <tr>
    <td>Full protection of Syrian hamsters: Antibody serum concentration of ~22 µg/ml.</td>
   </tr>
   <tr>
    <td rowspan="4">
     <p>COVA1-18</p>
     <p>COVA2-15</p>
    </td>
    <td rowspan="4">IgG</td>
    <td rowspan="4">Human</td>
    <td rowspan="4">B cells of convalescent patients</td>
    <td rowspan="4">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 8 ng/ml;
    </td>
    <td rowspan="4">
     <sup>
      <xref ref-type="bibr" rid="CR40">40</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 7 ng/ml.
    </td>
   </tr>
   <tr>
    <td>PsV neutralization: IC
     <sub>50</sub> = 8 ng/ml;
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 9 ng/ml.
    </td>
   </tr>
   <tr>
    <td rowspan="2">47D11</td>
    <td rowspan="2">IgG</td>
    <td rowspan="2">Chimeric antibody</td>
    <td rowspan="2">Transgenic mice; hybridoma technology</td>
    <td rowspan="2">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 0.061 μg/ml;
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR27">27</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 0.57 μg/ml.
    </td>
   </tr>
   <tr>
    <td rowspan="2">S309</td>
    <td rowspan="2">IgG</td>
    <td rowspan="2">human</td>
    <td rowspan="2">Peripheral blood of SARS-infected patients</td>
    <td rowspan="2">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 3.5 nM;
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR28">28</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 79 ng/ml.
    </td>
   </tr>
   <tr>
    <td>ADI-55689</td>
    <td rowspan="8">IgG</td>
    <td rowspan="8">Human</td>
    <td rowspan="8">Memory B cell repertoire of a convalescent SARS donor</td>
    <td rowspan="8">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 0.05 ~ 1.4 μg/ml;
    </td>
    <td rowspan="8">
     <sup>
      <xref ref-type="bibr" rid="CR41">41</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>ADI-55993</td>
    <td>LV neutralization: showed neutralizing activity at 100 nM.</td>
   </tr>
   <tr>
    <td>ADI-56000</td>
    <td rowspan="6"/>
   </tr>
   <tr>
    <td>ADI-55688</td>
   </tr>
   <tr>
    <td>ADI-56046</td>
   </tr>
   <tr>
    <td>ADI-56010</td>
   </tr>
   <tr>
    <td>ADI-55690</td>
   </tr>
   <tr>
    <td>ADI-55951</td>
   </tr>
   <tr>
    <td rowspan="8">
     <p>REGN10989</p>
     <p>REGN10987</p>
     <p>REGN10933</p>
     <p>REGN10934</p>
    </td>
    <td rowspan="8">IgG</td>
    <td rowspan="8">Human</td>
    <td rowspan="8">Transgenic mice; Peripheral blood of SARS-CoV-2-infected patients; Next Generation Sequencing</td>
    <td rowspan="8">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 7.23 pM;
    </td>
    <td rowspan="8">
     <sup>
      <xref ref-type="bibr" rid="CR42">42</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 7.38 pM.
    </td>
   </tr>
   <tr>
    <td>PsV neutralization: IC
     <sub>50</sub> = 40.6 pM;
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 42.1 pM.
    </td>
   </tr>
   <tr>
    <td>PsV neutralization: IC
     <sub>50</sub> = 42.8 pM;
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 37.4 pM.
    </td>
   </tr>
   <tr>
    <td>PsV neutralization: IC
     <sub>50</sub> = 54.4 pM;
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 28.3 pM.
    </td>
   </tr>
   <tr>
    <td rowspan="2">
     <p>H11-H4-Fc</p>
     <p>H11-D4-Fc</p>
    </td>
    <td rowspan="2">HCAb</td>
    <td rowspan="2">llama</td>
    <td rowspan="2">Phage display library</td>
    <td rowspan="2">RBD</td>
    <td>LV neutralization: ND
     <sub>50</sub> = 6 nM.
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR44">44</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: ND
     <sub>50</sub> = 18 nM.
    </td>
   </tr>
   <tr>
    <td>H014</td>
    <td>IgG</td>
    <td>Chimeric antibody</td>
    <td>Animal immunization and phage display</td>
    <td>RBD</td>
    <td>
     <p>PsV neutralization: IC
      <sub>50</sub> = 3 nM;
     </p>
     <p>LV neutralization: IC
      <sub>50</sub> = 38 nM;
     </p>
     <p>Protection of mice: Lung viral load reduced by about 10 ~100 folds compared with PBS control.</p>
    </td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR45">45</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td rowspan="4">
     <p>COV2-2196</p>
     <p>COV2-2130</p>
    </td>
    <td rowspan="4">IgG</td>
    <td rowspan="4">Human</td>
    <td rowspan="4">Peripheral blood of convalescent patients</td>
    <td rowspan="4">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 0.7 ng/ml;
    </td>
    <td rowspan="4">
     <sup>
      <xref ref-type="bibr" rid="CR47">47</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 15 ng/ml.
    </td>
   </tr>
   <tr>
    <td>PsV neutralization: IC
     <sub>50</sub> = 1.6 ng/ml;
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 107 ng/ml.
    </td>
   </tr>
   <tr>
    <td rowspan="3">2–15</td>
    <td rowspan="3">IgG</td>
    <td rowspan="3">Human</td>
    <td rowspan="3">Peripheral blood of COVID-19 patients</td>
    <td rowspan="3">RBD</td>
    <td>PsV neutralization: IC
     <sub>50</sub> = 0.7 ng/ml;
    </td>
    <td rowspan="3">
     <sup>
      <xref ref-type="bibr" rid="CR48">48</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: IC
     <sub>50</sub> = 5 ng/ml;
    </td>
   </tr>
   <tr>
    <td>Protection of hamsters: Viral RNA copy numbers and infectious virus titers in lung tissues were reduced by 4 logs or more compared with PBS control.</td>
   </tr>
   <tr>
    <td>CR3022</td>
    <td>IgG</td>
    <td>Human</td>
    <td>Gene cloning; Protein expression</td>
    <td>RBD</td>
    <td>LV neutralization: IC
     <sub>50</sub> = ~ 0.114 μg/ml.
    </td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR55">55</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td rowspan="2">4A8</td>
    <td rowspan="2">IgG</td>
    <td rowspan="2">Human</td>
    <td rowspan="2">Peripheral blood of convalescent patients</td>
    <td rowspan="2">NTD</td>
    <td>PsV neutralization: EC
     <sub>50</sub> = 49 μg/ml;
    </td>
    <td rowspan="2">
     <sup>
      <xref ref-type="bibr" rid="CR56">56</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>LV neutralization: EC
     <sub>50</sub> = 0.61 μg/ml.
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>PsV</italic> pseudovirus, 
   <italic>LV</italic> live virus
  </p>
 </table-wrap-foot>
</table-wrap>
